Our findings revealed a significant elevation of HRH1 levels in human HNSCC and OSCC tissues, with its upregulation correlating with disease progression and serving as an independent prognostic factor in OSCC patients. This evidence concerns the gene HRH1 and head and neck squamous cell carcinoma.